ImmunoGen Inc. said Monday the Food and Drug Administration and European regulators gave the company's potential cancer drug IMGN901 "orphan drug" status. Orphan drug status is given to drugs aimed at rare conditions or conditions that have a lack of treatments on the market. Incentives in the U ...

Medical lab operator Quest Diagnostics Inc. said Monday it is selling the OVA1 blood test, which aims to better assess a woman's likelihood for ovarian cancer. The OVA1 test, which was approved by the Food and Drug Administration in September, will be sold through Quest, based in Madison ...

NEW YORK (Reuters Health) - People with Parkinson's disease face an increased risk of the most deadly type of skin cancer, new research confirms. Exams of more than 2,000 people with Parkinson's disease found that about 1 percent currently had melanoma, Dr. John M. Bertoni of the University of Nebraska Medical Center in Omaha and his colleagues found ...

NEW YORK (Reuters Health) - New research suggests that the type of specialist a prostate cancer patient sees -- rather than the patient's own preference -- may determine the treatment he receives. This is problematic, the study's authors say, because none of the options now available for treating localized prostate cancer have been shown to be any better than the others ...